Edward A. Weinstein

1.8k total citations
23 papers, 1.4k citations indexed

About

Edward A. Weinstein is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, Edward A. Weinstein has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Edward A. Weinstein's work include Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers) and COVID-19 Clinical Research Studies (3 papers). Edward A. Weinstein is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers) and COVID-19 Clinical Research Studies (3 papers). Edward A. Weinstein collaborates with scholars based in United States, United Kingdom and Italy. Edward A. Weinstein's co-authors include Harvey Rubin, Linsheng Li, Takahiro Yano, David Avarbock, Jeffrey D. Rothstein, Peter Bannerman, Karen E. Davis, Michael B. Robinson, Sanjay K. Jain and Alvaro A. Ordoñez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Edward A. Weinstein

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward A. Weinstein United States 14 557 382 323 226 225 23 1.4k
Christine Oswald United States 23 760 1.4× 159 0.4× 114 0.4× 56 0.2× 164 0.7× 56 1.6k
Birgit Sehested Hansen Denmark 23 536 1.0× 113 0.3× 225 0.7× 220 1.0× 104 0.5× 49 1.8k
Virendra K. Sharma United States 27 1.4k 2.5× 306 0.8× 312 1.0× 192 0.8× 565 2.5× 60 2.4k
Deborah H. Smith United States 21 797 1.4× 57 0.1× 236 0.7× 54 0.2× 318 1.4× 37 1.8k
Nobukazu Ono Japan 16 533 1.0× 120 0.3× 154 0.5× 46 0.2× 26 0.1× 23 1.1k
King‐Hwa Ling Malaysia 27 978 1.8× 101 0.3× 78 0.2× 112 0.5× 172 0.8× 114 1.9k
Dustin Singer Switzerland 13 664 1.2× 226 0.6× 77 0.2× 109 0.5× 45 0.2× 14 1.3k
David A. Sykes United Kingdom 21 1.2k 2.2× 37 0.1× 161 0.5× 186 0.8× 449 2.0× 57 2.1k
Clive Bate United Kingdom 33 1.3k 2.4× 182 0.5× 324 1.0× 129 0.6× 271 1.2× 96 3.3k
Michael A. Cook Canada 19 1.3k 2.3× 73 0.2× 79 0.2× 87 0.4× 170 0.8× 44 2.0k

Countries citing papers authored by Edward A. Weinstein

Since Specialization
Citations

This map shows the geographic impact of Edward A. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Weinstein more than expected).

Fields of papers citing papers by Edward A. Weinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward A. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Weinstein. The network helps show where Edward A. Weinstein may publish in the future.

Co-authorship network of co-authors of Edward A. Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Edward A. Weinstein. A scholar is included among the top collaborators of Edward A. Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward A. Weinstein. Edward A. Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weinstein, Edward A., Roger Paredes, Annie Gardner, et al.. (2025). Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial. The Lancet Infectious Diseases. 25(11). 1243–1253. 3 indexed citations
2.
3.
4.
Wei, Xiaohui, et al.. (2022). Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy. Clinical Pharmacology & Therapeutics. 112(5). 1004–1007. 10 indexed citations
5.
Weinstein, Edward A., Abhay Joshi, Simone M. Shurland, et al.. (2020). FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development. Antimicrobial Agents and Chemotherapy. 65(1). 13 indexed citations
6.
Zhang, Zhuo, Alvaro A. Ordoñez, Hui Wang, et al.. (2018). Positron Emission Tomography Imaging with 2-[18F]F-p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response. ACS Infectious Diseases. 4(11). 1635–1644. 63 indexed citations
7.
Ordoñez, Alvaro A., Edward A. Weinstein, Vikram Saini, et al.. (2016). A Systematic Approach for Developing Bacteria-Specific Imaging Tracers. Journal of Nuclear Medicine. 58(1). 144–150. 82 indexed citations
8.
Johnson, Daniel, Laura E. Via, Peter Kim, et al.. (2014). Nuclear imaging: A powerful novel approach for tuberculosis. Nuclear Medicine and Biology. 41(10). 777–784. 21 indexed citations
9.
Weinstein, Edward A., Alvaro A. Ordoñez, Vincent P. DeMarco, et al.. (2014). Imaging Enterobacteriaceae infection in vivo with 18 F-fluorodeoxysorbitol positron emission tomography. Science Translational Medicine. 6(259). 259ra146–259ra146. 171 indexed citations
10.
Yano, Takahiro, Linsheng Li, Edward A. Weinstein, J. S. Teh, & Harvey Rubin. (2006). Steady-state Kinetics and Inhibitory Action of Antitubercular Phenothiazines on Mycobacterium tuberculosis Type-II NADH-Menaquinone Oxidoreductase (NDH-2). Journal of Biological Chemistry. 281(17). 11456–11463. 118 indexed citations
11.
Weinstein, Edward A., Takahiro Yano, Linsheng Li, et al.. (2005). Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proceedings of the National Academy of Sciences. 102(12). 4548–4553. 219 indexed citations
12.
Kana, Bavesh D, Edward A. Weinstein, David Avarbock, et al.. (2001). Characterization of the cydAB -Encoded Cytochrome bd Oxidase from Mycobacterium smegmatis. Journal of Bacteriology. 183(24). 7076–7086. 123 indexed citations
13.
Weinstein, Edward A., Hongwei Li, John A. Lawson, et al.. (2000). Prothrombinase Acceleration by Oxidatively Damaged Phospholipids. Journal of Biological Chemistry. 275(30). 22925–22930. 23 indexed citations
14.
Weinstein, Edward A., D.Sunita Rao, Mei-Ling Siu–Caldera, et al.. (1999). Isolation and identification of 1α-hydroxy-24-oxovitamin D 3 and 1α,23-dihydroxy-24-oxovitamin D 3. Biochemical Pharmacology. 58(12). 1965–1973. 8 indexed citations
15.
Davis, Karen E., et al.. (1998). Multiple Signaling Pathways Regulate Cell Surface Expression and Activity of the Excitatory Amino Acid Carrier 1 Subtype of Glu Transporter in C6 Glioma. Journal of Neuroscience. 18(7). 2475–2485. 254 indexed citations
16.
Mentis, Marc J., Edward A. Weinstein, Barry Horwitz, et al.. (1995). Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease. Biological Psychiatry. 38(7). 438–449. 102 indexed citations
17.
Weinstein, Edward A., et al.. (1989). So You Want to Do a Leveraged Buyout. Journal of Business Strategy. 10(1). 10–14. 2 indexed citations
18.
19.
Weinstein, Edward A., A Manitius, & Franklin H. Epstein. (1969). The importance of aerobic metabolism in the renal concentrating process. Journal of Clinical Investigation. 48(10). 1855–1861. 13 indexed citations
20.
Weinstein, Edward A., et al.. (1964). Boeing SLIP: Computer produced and maintained printed book catalogs. American Documentation. 15(3). 185–190. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Oswald Breakdown of academic impact, for papers by Birgit Sehested Hansen Breakdown of academic impact, for papers by Virendra K. Sharma Breakdown of academic impact, for papers by Deborah H. Smith Breakdown of academic impact, for papers by Nobukazu Ono Breakdown of academic impact, for papers by King‐Hwa Ling Breakdown of academic impact, for papers by Dustin Singer Breakdown of academic impact, for papers by David A. Sykes Breakdown of academic impact, for papers by Clive Bate Breakdown of academic impact, for papers by Michael A. Cook
Rankless by CCL
2026